Myasthenia Gravis

Latest News

Myasthenia gravis | Image Credit: © missbobbit-stock.adobe.com
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod

April 18th 2025

Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.

ClinicalData | Image Credit: © tippapatt-stock.adobe.com
Areas of Unmet Need Continue to Burden Patients With gMG

April 2nd 2025

Myasthenia Gravis | Image Credit: © lexiconimages-stock.adobe.com
MINT Trial 26-Week Data Show Inebilizumab for gMG Is Effective and Safe

April 1st 2025

Rystiggo | Image Credit: © UCB
Rozanolixizumab Remains Consistently Safe, Effective for gMG

March 21st 2025

FDA approval | Image Credit: © Olivier Le Moal-stock.adobe.com
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis

March 15th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo